
About Excelencia Pharmaceuticals Private Limited
Data last updated:
Excelencia Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2016PTC094731. Its GSTIN is 24AAECE4680P1Z7 (Gujarat).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Vaishali Parag Solanki and Chaitali Kaushal Anand.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.67 Lakh, a decline of 69% compared to the previous year. For the same year it recorded a net profit of ₹3.94 Lakh (net margin 59.1%) and EBITDA of ₹4.44 Lakh (EBITDA margin 66.6%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 52% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website excelenciapharma.com.
Company details
Contact details
Excelencia Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its website is excelenciapharma.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressUnit No 203 Block No. C Second Floor Abhishek Complex – 1 Asa, Sarva, Ahmedabad, Gujarat, India – 380016
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Excelencia Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Excelencia Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Excelencia Pharmaceuticals Private Limited, buy the company report.
Financials of Excelencia Pharmaceuticals Private Limited
FY 2025 filings availableExcelencia Pharmaceuticals Private Limited reported revenue of ₹6.67 Lakh (down 69% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 69% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 52%. EBITDA fell 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.44 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.94 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 66.6% | ||||
| Net Profit Margin | 59.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Excelencia Pharmaceuticals Private Limited, buy the company report.
Board of directors of Excelencia Pharmaceuticals Private Limited
Excelencia Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vaishali Parag Solanki | Director | 16 Dec 2016 | 9 Years 10 Months | Current |
| Chaitali Kaushal Anand | Director | 16 Dec 2016 | 9 Years 10 Months | Current |
Auditor
Excelencia Pharmaceuticals Private Limited is audited by NAUTAM R VAKIL & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NAUTAM R VAKIL & CO | FY 2021 | 106980W |
Shareholding
The shareholding of Excelencia Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Excelencia Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Excelencia Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Excelencia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Excelencia Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECE4680P1Z7 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Excelencia Pharmaceuticals Private Limited, buy the company report.
Recent activity
Excelencia Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Monil Akhtarbhai Laliwala ceased to be Managing Director on 02 Apr 2019.
Frequently asked questions
Excelencia Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 December 2016 (10+ years old) and is registered under CIN U74999GJ2016PTC094731.
Excelencia Pharmaceuticals has 2 current directors:
- Vaishali Parag Solanki - Director
- Chaitali Kaushal Anand - Director
The latest financial statements of Excelencia Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Excelencia Pharmaceuticals is 24AAECE4680P1Z7, registered in Gujarat.
The CIN (Corporate Identification Number) of Excelencia Pharmaceuticals is U74999GJ2016PTC094731. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Excelencia Pharmaceuticals was incorporated on 16 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Monil Akhtarbhai Laliwala ceased to be Managing Director on 02 Apr 2019. Chaitali Kaushal Anand was appointed as Director on 16 Dec 2016. Vaishali Parag Solanki was appointed as Director on 16 Dec 2016.
Excelencia Pharmaceuticals can be reached through the website excelenciapharma.com. Its registered office is in Ahmedabad, Gujarat, India.
The registered office of Excelencia Pharmaceuticals is at Unit No 203 Block No. C Second Floor Abhishek Complex – 1 Asa, Sarva, Ahmedabad, Gujarat, India – 380016.
Excelencia Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

